Sfoglia per AUTORE
GALLI S
Collezione ASL Città di Torino

  

Items : 9

VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Digestive and Liver Disease

2020
ASL Città di Torino

Ceccherini-Silberstein F; Craxì A; Perno CF; Angelico M; Andreoni M; Zazzi M; Raimondo G; Puoti M; Gaeta GB; Baldanti F; Coppola N; Parruti G; Lampertico P; Ghisetti V; Beretta I; Cariti G; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Giorgini A; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Giannelli V; Rizzardini G; Ganga R; et alii...

Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience in Digestive and Liver Disease

2019
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Craxì A; Angelico M; Andreoni M; Raimondo G; Zazzi M; Coppola N; Parruti G; Giorgini A; Lampertico P; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Santantonio T; Di Stefano M; Taliani G; Babudieri S; Lichtner M; De Santis A; Cozzolongo R; Colombatto P; Brunetto M; et alii...

Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance in Digestive and Liver Disease

2019
ASL Città di Torino

Perno CF; Ceccherini-Silberstein F; Craxì A; Andreoni M; Baldanti F; Angelico M; Pasquazzi C; Parruti G; Lampertico P; Taliani G; Babudieri S; Rizzardini G; Pellicelli A; Puoti M; Paba P; Sarmati L; Borghi V; Lichtner M; Guarneri V; Siciliano M; Morisco F; Iapadre N; Maserati R; Bonora S; Micheli V; Boccaccio V; Galli S; Magni CF; Campoli R; et alii...

Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology

2019
ASL Città di Torino

Silberstein FC; Perno CF; Mario A; Andreoni M; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Babudieri S; Pellicelli A; Craxi A; Sarmati L; Puoti M; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Bonora S; Iapadre N; Maserati R; Boccaccio V; Micheli V; Galli S; Magni CF; Campoli R; Borghi V; Nicolini LA; et alii...

Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology

2019
ASL Città di Torino

Ceccherini Silberstein F; Federico Perno C; Andreoni M; Mario A; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Pellicelli A; Babudieri S; Craxi A; Puoti M; Sarmati L; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Iapadre N; Bonora S; Maserati R; Boccaccio V; Micheli V; Federico Magni C; Galli S; Campoli R; Borghi V; Ambra Nicolini L; et alii...

Italian real life experience of resistanceguided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Perno CF; Craxì A; Angelico M; Andreoni M; Zazzi M; Raimondo G; Coppola N; Parruti G; Lampertico P; Beretta I; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Di Lorenzo F; Giorgini A; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Di Stefano M; Santantonio TA; Taliani G; Biliotti E; et alii...

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? in Journal of hepatology / J Hepatol. 2018 Mar;68(3):597-600. doi: 10.1016/j.jhep.2017.09.008. Epub 2017 Sep 20.

2018
ASL Città di Torino

Ceccherini-Silberstein F; Baldanti F; Raimondo G; Perno CF; Barbaliscia S; Galli S; Gennari W; Zazzi M; Brunetto M; Bertoli A; Coppola N; Bruzzone B; Ghisetti V; Di Maio VC; Pollicino T; Paolucci S; Aragri M; Cento V;

National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing in Digestive and Liver Disease

2018
ASL Città di Torino

Craxì A; Perno CF; Ceccherini-Silberstein F; Zazzi M; Vatteroni ML; Starace M; Soldini S; Santangelo R; Santantonio T; Sanguinetti M; Sampaolo M; Raimondo G; Raffa G; Raddi A; Pollicino T; Paolucci S; Monno L; Micheli V; Minosse C; Menzo S; Lai A; Gennari W; Garbuglia AR; Galmozzi E; Galli S; Cuomo N; Caudai C; Capobianchi MR; Callegaro AP; et alii...

National quality control and validation of hepatitis C NS3, NS5A and NS5B genotypic resistance testing in Journal of Hepatology

2018
ASL Città di Torino

Zazzi M; Silberstein FC; Perno CF; Craxi A; Vatteroni ML; Starace M; Soldini S; Santantonio T; Santangelo R; Sanguinetti M; Raimondo G; Raffa G; Raddi A; Pollicino T; Paolucci S; Monno L; Minosse C; Micheli V; Menzo S; Lai A; Gennari W; Garbuglia A; Galmozzi E; Galli S; Cuomo N; Caudai C; Capobianchi MR; Callegaro MP; Ghisetti V; et alii...